Rhinitis, Allergic, Seasonal: all 396 studies
Page 3 of 4. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen AllergyCompletedNCT02469688Phase 1
- Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic RhinitisCompletedNCT02377895Phase 1/2
- A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic RhinitisStatus unknownNCT02279563Phase 2
- A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic RhinitisCompletedNCT02273817Phase 3
- Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownNCT02249663Phase 3
- Study of Grass-SPIRE in Subjects With Grass Allergies and AsthmaCompletedNCT02161107Phase 2
- Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TMCompletedNCT02156791Phase 2
- Effect of the Nasal Provocation on the Breathing StyleStatus unknownNCT02146300Not applicable
- Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic RhinitisCompletedNCT02130440Phase 3
- Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisCompletedNCT02125253Phase 3
- A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female VolunteersCompletedNCT02109185Phase 1
- Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay FeverCompletedNCT02108574Not applicable
- Compliance and Usability Study Evaluating RHINIX™ Nasal FiltersCompletedNCT02108379Not applicable
- Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen ExposureCompletedNCT02074930Not applicable
- Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure ChamberCompletedNCT02061709Phase 2
- Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and AsthmaCompletedNCT02061670Phase 2
- Post Marketing Surveillance for Contac Bien Z in JapanCompletedNCT02020902
- Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic RhinitisCompletedNCT02014623Phase 4
- To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.CompletedNCT01984541Phase 2
- Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)CompletedNCT01983865Not applicable
- Regulatory T-cells After Subcutaneous ImmunotherapyCompletedNCT01830673
- POLlinosis and Exhaled Breath TemperatureStatus unknownNCT01785394Phase 4
- Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic RhinitisCompletedNCT01748344Phase 2
- Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic RhinoconjunctivitisCompletedNCT01731249Phase 3
- Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)CompletedNCT01699165Not applicable
- A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy TabletCompletedNCT01675791Phase 2
- A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)CompletedNCT01673659Phase 3
- Effect of a Probiotic on Seasonal Allergic Rhinitis SymptomsCompletedNCT01653652Not applicable
- Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic RhinitisCompletedNCT01651871Phase 2
- Physiological Study to Determine the Allergic Skin Activity After Different Skin PreparationCompletedNCT01628484Phase 1
- Comparison of Perennial and Preseasonal Subcutaneous ImmunotherapyCompletedNCT01555736Phase 4
- Phase II Study of Grass Pollen Allergy Vaccine BM32CompletedNCT01538979Phase 2
- Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/ActuationCompletedNCT01523236Phase 1/2
- Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating AdjuvantCompletedNCT01506375Phase 2
- Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual ImmunotherapyCompletedNCT01500642Phase 3
- Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic RhinitisCompletedNCT01484119Phase 3
- An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.CompletedNCT01480271Phase 1
- Regulatory Lymphocytes in Patients Treated With Specific ImmunotherapyCompletedNCT01475188Phase 4
- Sublingual Immunotherapy of Birch Pollen Associated Apple AllergyCompletedNCT01449786Phase 2
- Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen AllergyCompletedNCT01445002Phase 2
- Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic RhinitisCompletedNCT01400828Phase 3
- A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT01368445Phase 3
- Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed AllergyCompletedNCT01361412Phase 2
- Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and AdolescentsCompletedNCT01342601Not applicable
- Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy SettingTerminatedNCT01337323
- Long-Term Effects of Sublingual Grass TherapyCompletedNCT01335139Phase 2
- Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic RhinitisCompletedNCT01326247Phase 4
- Rhinitis, Cognition and Driving PerformanceCompletedNCT01318681Not applicable
- Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic RhinoconjunctivitisCompletedNCT01308021Phase 2
- Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic RhinitisCompletedNCT01306721Phase 3
- Trial of STAHIST in Seasonal Allergic RhinitisCompletedNCT01293201Phase 3
- Reduction of IgE Antibody in Human Allergic SubjectsCompletedNCT01280149Phase 1
- AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis PatientsCompletedNCT01271595Not applicable
- Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal ChallengeCompletedNCT01260753Phase 2
- Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic ConjunctivitisCompletedNCT01258309Phase 3
- Study of ACT-129968 in Adult Patients With Seasonal Allergic RhinitisCompletedNCT01241214Phase 2
- Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic RhinitisCompletedNCT01230619Phase 2
- Safety and Tolerability Study of Ragweed SLIT TabletsCompletedNCT01224834Phase 1
- Eosinophil Markers and Development of Disease in Allergic RhinitisCompletedNCT01192386
- Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai PopulationStatus unknownNCT01172613
- Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) SubjectsCompletedNCT01171664Phase 2
- Probiotics for Reduction Of Markers In Subjects With AllergyCompletedNCT01137357Not applicable
- Seasonal Allergic Rhinitis StudyCompletedNCT01123252Phase 2
- A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With BilastineCompletedNCT01108783Phase 3
- A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.CompletedNCT01064726Phase 1
- A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal AllergiesCompletedNCT01054352Phase 1
- A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune ToleranceCompletedNCT01018693Phase 2
- Study of AHIST in Seasonal Allergic Rhinitis PatientsWithdrawnNCT01008397Phase 1
- Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of SeasonCompletedNCT01007721Phase 2
- A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic RhinitisCompletedNCT00987233Phase 3
- Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic RhinitisCompletedNCT00940953Phase 2
- Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of ARCompletedNCT00938613Phase 2
- SUBLIVAC® Birch PROBE StudyCompletedNCT00932607Phase 2
- Clinical Trial of STAHIST in Seasonal Allergic Rhinitis PatientsCompletedNCT00932256Phase 1
- DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCompletedNCT00925678Phase 1
- Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).CompletedNCT00917488Phase 2
- The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00917111Phase 2
- The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00917020Phase 2
- Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass PollenCompletedNCT00916422Phase 3
- Study of rBet v1 TabletsCompletedNCT00901914Phase 2
- Safety and Tolerability Study of rBet v1 SLIT TabletsCompletedNCT00889460Phase 1
- Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)CompletedNCT00867191Phase 4
- MOA Study of Ze 339 in Seasonal Allergic RhinitisCompletedNCT00862225Phase 2
- Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With PlaceboCompletedNCT00851344Phase 2
- Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic AdultsCompletedNCT00839189Phase 1
- Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)CompletedNCT00816972Phase 2
- Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)CompletedNCT00807053Phase 2
- Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)CompletedNCT00805584Phase 4
- Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)CompletedNCT00805324Phase 3
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)CompletedNCT00794846Phase 4
- Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)CompletedNCT00794768Phase 4
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)CompletedNCT00794599Phase 4
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)CompletedNCT00794495Phase 4
- Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)CompletedNCT00794248Phase 4
- A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00784732Phase 2
- Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)CompletedNCT00783211Phase 4
- Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)CompletedNCT00783146Phase 4
- Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)CompletedNCT00783133Phase 4
- A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax TreatmentCompletedNCT00773240Phase 3
- Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)CompletedNCT00762983